Bharat Biotech

Bharat Biotech, one of India's COVID-19 vaccine manufacturers, announced phase 3 interim analysis results of COVAXIN on Wednesday. The se...Read More

Hyderabad: Bharat Biotech on Tuesday said it has scaled up its COVID-19 vaccine Covaxin manufacturing capacity to 700 million doses per a...Read More

A month's national lockdown can hurt GDP growth by 2 percentage points, an American brokerage warned on Monday while expecting government...Read More

The Ministry of Finance on Monday approved to sanction supply credit to India's COVID-19 vaccine manufacturers Serum Institute of India a...Read More

The regulator apparently had a rethink due to the absence of some key documents and lack of what it describes as GMP issues

The Brazilian health regulator Anvisa has denied permission to import Bharat Biotech's COVID-19 vaccine 'Covaxin' into the country after ...Read More

Speed up the rolloutThe findings of the first interim analysis of the Phase III clinical trials of Bharat Biotech’s Covaxin have come as ...Read More

The high court further directed the two institutes to file separate affidavits listing their capacity to manufacture vaccines per day/ we...Read More

The company revealed that, analysis from the National Institute of Virology indicates that vaccine-induced antibodies can neutralise the ...Read More

MUMBAI: The Chinese disruptive attempts are not restricted to inflicting power outages but also hacking IT systems of Indian vaccine make...Read More

Biopharmaceutical company Ocugen and vaccine developer Bharat Biotech have entered an agreement to codevelop, supply, and commercialise ...Read More

Amid reports of side effects, Bharat Biotech on Tuesday issued a set of cautionary guidelines and asked people who are immuno-compromised...Read More

As the vaccinaton drive against Covid-19 began on Saturday, those taking 'COVAXIN' vaccine manufactured by Bharat Biotech are asked to si...Read More